Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
0% from low
Exchange
OTC Link
OS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $38.6K | $186.4K | $321.6K | $1.2M | $0 | $0 | $0 | $0 |
| Cost of revenue | $45.2K | $147.4K | $156.3K | $0 | $44.8K | $45.1K | $41.3K | $41.7K |
| Gross profit | −$6.5K | $39.0K | $165.4K | $1.2M | −$44.8K | −$45.1K | −$41.3K | −$41.7K |
| Gross margin | -16.9% | 20.9% | 51.4% | 100.0% | — | — | — | — |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$591.5K | −$487.2K | −$707.9K | −$6.3M | −$5.7M | −$11.2M | −$4.8M | −$2.4M |
| EBITDA | −$379.4K | −$221.4K | −$171.4K | −$6.8M | −$5.3M | −$11.2M | −$4.8M | −$2.4M |
| Net income | −$591.5K | −$487.2K | −$668.2K | −$7.5M | −$9.6M | −$24.2M | −$25.2M | −$4.7M |
| Net margin | -1531.8% | -261.3% | -207.8% | -636.9% | — | — | — | — |
| EPS (diluted) | -0.15 | -0.09 | -0.12 | -0.33 | -0.75 | -0.26 | -0.18 | -0.03 |
Annual figures · source: Financial Modeling Prep
ISRACANN BIOSCIENCES INC
No one on the platform currently holds ISCNF.
No tracked institution reports a position in ISCNF as of their last filing.
No one on the platform has traded ISCNF yet.
| $51M |
| — |
| EVRRFMolecule Holdings Inc. | $0.00 | +0.00% | $626130 | — |
| GBLPGlobal Pharmatech, Inc. | $0.08 | +0.00% | $33M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.